The paper describes the transparency process in the pharmaceutical industry in UE. Recent socio-economical changes put more attention on social and ethical performance of enterprises. The European Federation of Pharmaceutical Industries and Associations (EFPIA) adopted the Code on Disclosure of Transfer of Value from Pharmaceutical Companies to Healthcare Professionals and Healthcare Organisation. The proposal of the Code was that the EFPIA members pharmaceutical companies, since 2016, would publish all data related to the transfer of values made to healthcare professionals. The paper analyse main concerns and the outcomes of this initiative.